Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03724747
Title Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Anti-tumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FIN

Facility Status City State Zip Country Details
Tulane Medical Center New Orleans Louisiana 70112 United States Details
GU Research Network, LLC Omaha Nebraska 68130 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
HUS, Meilahden sairaala Helsinki FIN-00260 Finland Details
Royal Marsden NHS Trust (Surrey) Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field